Research Database
Our peptide information and educational content are grounded in peer-reviewed scientific literature. Explore the credible sources and key studies that inform our research resources.
Primary Research Sources
These databases and platforms house the peer-reviewed studies, clinical trials, and scientific literature that form the foundation of our peptide resources.
AI Research Tool
Semantic Scholar
AI-powered research tool that uses machine learning to find relevant scientific papers, track citations, and identify influential studies in peptide research.
AI-Powered Search Citation Graphs Trend Analysis
Structure Archive
RCSB Protein Data Bank
Archive of experimentally determined 3D structures of proteins, nucleic acids, and complex assemblies. Essential for understanding peptide conformations and binding sites.
3D Structures Crystallography Binding Sites
Chemistry Database
PubChem
Open chemistry database maintained by NCBI. Contains detailed chemical structures, bioassay data, and biological activity information for peptides and small molecules.
Chemical Structures Bioassay Data Compound Profiles
Systematic Reviews
Cochrane Library
Gold-standard collection of systematic reviews and meta-analyses. Provides the highest level of evidence-based research summaries across biomedical fields.
Systematic Reviews Meta-Analyses Evidence Grading
Protein Database
UniProt
Universal protein resource providing comprehensive, high-quality protein sequence and functional information including peptide structures.
Protein Sequences Structure Data Functional Annotations
Drug Database
DrugBank
Comprehensive pharmaceutical database with detailed drug and peptide information including pharmacodynamics, mechanisms, and interactions.
Drug Interactions Pharmacodynamics Molecular DataFeatured Research Studies
Key peer-reviewed studies that have shaped our understanding of peptide mechanisms, dosing protocols, and safety considerations.
Retatrutide for Long-Term Weight Maintenance in Adults with Obesity (TRIUMPH-3)
Phase 3 TRIUMPH-3 trial evaluating sustained weight loss and cardiometabolic outcomes with retatrutide over 88 weeks in adults with obesity.
Tirzepatide and MACE Reduction in Type 2 Diabetes with Established CVD (SURPASS-CVOT)
Cardiovascular outcomes trial reporting major adverse cardiovascular event reduction with tirzepatide versus dulaglutide in high-risk T2D patients.
Pharmacokinetics and Tendon Repair Outcomes of BPC-157 in a Randomized Controlled Pilot
First randomized controlled pilot characterizing BPC-157 pharmacokinetics and patient-reported tendon repair outcomes following subcutaneous administration.
CagriSema versus Tirzepatide for Obesity: 68-Week Head-to-Head Trial
Head-to-head Phase 3 comparison of CagriSema and tirzepatide showing differentiated weight loss, tolerability, and body composition outcomes.
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Pilot study by Lee & Burgess evaluating the safety profile of intravenous BPC-157 administration in human subjects.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Phase 2 trial by Jastreboff et al. evaluating the triple-hormone-receptor agonist retatrutide for obesity treatment.
Research Disclaimer
The research sources and studies listed on this page are provided for educational and informational purposes only. All peptides sold by our company are intended strictly for laboratory and research use. We do not make any therapeutic claims. Researchers should always consult the original publications and follow applicable regulations.